Fidelity Investments’s Upstream Bio UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.1M Buy
8,181,586
+18,689
+0.2% +$122K ﹤0.01% 1563
2026
Q2
$56.5M Buy
8,162,897
+61,334
+0.8% +$514K ﹤0.01% 1464
2026
Q1
$72.9M Buy
8,101,563
+583,361
+8% +$10.5M ﹤0.01% 1290
2025
Q4
$204M Sell
7,518,202
-568,211
-7% -$14.1M 0.01% 854
2025
Q3
$152M Buy
8,086,413
+149,533
+2% +$2.32M 0.01% 975
2025
Q2
$87.1M Buy
7,936,880
+681,021
+9% +$6.29M ﹤0.01% 1178
2025
Q1
$44.4M Buy
7,255,859
+79,672
+1% +$761K ﹤0.01% 1400
2024
Q4
$118M Buy
+7,176,187
New +$160M 0.01% 1048

Other funds holding UPB

Fidelity Investments's UPB Position: Q3 2026 in Review

Fidelity Investments increased its Upstream Bio (UPB) stake by 0.23% in Q3 2026, buying an estimated $122K and bringing the position to 8,181,586 shares worth $43.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

Fidelity Investments first reported a position in UPB in Q4 2024 and has held it in 8 quarters since. The position peaked at $204M in Q4 2025. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.

  • Fidelity Investments held 8,181,586 shares of Upstream Bio worth $43.1M as of Q3 2026.
  • Fidelity Investments bought 18,689 Upstream Bio shares in Q3 2026, an estimated $122K.
  • Upstream Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1563 holding.
  • Fidelity Investments first reported a position in Upstream Bio in Q4 2024 and has held it in 8 quarters since.
  • Fidelity Investments's Upstream Bio position peaked at $204M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.